Acute Alcohol Response In Bipolar Disorder: a fMRI Study
NCT04063384 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-12-11
Summary
Alcohol use disorders (AUDs) affect up to 60% of individuals with bipolar disorder during their lifetime-a rate 3 to 5 times higher than what occurs in the general population. The mechanisms that contribute to elevated rates of comorbidity are not known. Early identification in individuals with bipolar disorder who are at risk for AUDs could inform novel intervention strategies and improve life-long outcomes. The primary objective of this protocol is to use alcohol administration procedures and functional MRI techniques to investigate subjective response to alcohol, compared to placebo, and relationship with functional responses of, and connectivity among, brain regions in ventral prefrontal emotional networks in young adults with bipolar disorder and healthy comparison young adults. Baseline clinical and structural MRI assessments will be completed in 30 bipolar and 30 healthy young adults (21-26 years of age, 50% women). Then, following standard beverage administration procedures, participants will complete within-person, counter-balanced, fMRI scans and complete measures of subjective response to alcohol while under the influence of alcohol or placebo. Specifically, individual differences in the experience of stimulating, sedative, and anxiolytic effects of alcohol (measured with self-report surveys) and individual differences in neural responses to alcohol within ventral prefrontal emotional networks will be investigated and differences in bipolar disorder compared to healthy participants assessed. Functional MRI scans during a continuous performance task with emotional and neutral distractors (CPT-END) and at rest will be collected while under the influence of alcohol and placebo and compared. Experience of stimulating, sedative, and anxiolytic effects of alcohol from self-report survey data and neural responses to emotional stimuli while under the influence of alcohol compared to placebo will be the primary data outcomes assessed. Additionally, associations between subjective and neural response to alcohol and drinking patterns will be explored (secondary outcomes). The primary endpoint of the study will be after completion of both alcohol and placebo beverage conditions.
Conditions
- Bipolar Disorder
- Alcohol Drinking
- Alcohol Use Disorder
Interventions
- OTHER
-
alcohol beverage
Participants will be provided alcohol during study visits and changes in behavior/neural activity after consuming alcohol will be examined.
- OTHER
-
Placebo beverage
placebo beverage conditions.
Sponsors & Collaborators
-
University of Texas at Austin
lead OTHER
Principal Investigators
-
Elizabeth Lippard, PhD · University of Texas at Austin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 26 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-22
- Primary Completion
- 2024-03-31
- Completion
- 2024-03-31
Countries
- United States
Study Locations
More Related Trials
-
Naltrexone for Bipolar Disorder and Alcohol Dependence
NCT00223275 ·Status: COMPLETED ·Phase: PHASE4
-
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Functional Connectivity in Alcohol Use Disorder
NCT02877849 ·Status: COMPLETED
-
Approach-Avoidance and Alcohol Challenge Study in PTSD
NCT06002633 ·Status: RECRUITING ·Phase: NA
-
Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes
NCT03056872 ·Status: COMPLETED
-
The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.
NCT00230425 ·Status: COMPLETED
-
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
NCT02082678 ·Status: COMPLETED ·Phase: PHASE4
-
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
NCT00572117 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Positive and Negative Emotions on Brain Activity in Alcoholics and Nonalcoholics
NCT00001675 ·Status: COMPLETED
-
Neural Mechanisms Underlying Alcohol Induced Disinhibition
NCT01097213 ·Status: COMPLETED
-
Anxiety During Abstinence in AUD
NCT06793488 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Neurobiology of Alcohol and Nicotine Co-Addiction
NCT03338933 ·Status: COMPLETED
-
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
NCT06795581 ·Status: RECRUITING ·Phase: PHASE1
-
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
NCT07027839 ·Status: RECRUITING ·Phase: PHASE1
-
Multimodal Neuroimaging of Alcohol Cues, Cortisol Response, and Compulsive Motivation
NCT04412824 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
NCT02646449 ·Status: COMPLETED ·Phase: PHASE2
-
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Valproate for Mood Swings and Alcohol Use Following Head Injury
NCT01760785 ·Status: COMPLETED ·Phase: NA
-
Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers
NCT06885190 ·Status: NOT_YET_RECRUITING
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving
NCT05305404 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
NCT02181569 ·Status: COMPLETED
-
Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation
NCT07188376 ·Status: RECRUITING ·Phase: NA